Home > Research > Publications & Outputs > The E1 copper binding domain of full-length amy...

Electronic data

  • 1-s2.0-S0006291X14017902-main

    Rights statement: Open Access funded by Cancer Research UK Under a Creative Commons license

    Final published version, 716 KB, PDF document

    Available under license: CC BY-NC-ND

Links

Text available via DOI:

View graph of relations

The E1 copper binding domain of full-length amyloid precursor protein mitigates copper-induced growth inhibition in brain metastatic prostate cancer DU145 cells

Research output: Contribution to journalJournal article

Published
Close
<mark>Journal publication date</mark>31/10/2014
<mark>Journal</mark>Biochemical and Biophysical Research Communications
Issue number4
Volume453
Number of pages7
Pages (from-to)741-747
Publication statusPublished
Early online date11/10/14
Original languageEnglish

Abstract

Copper plays an important role in the aetiology and growth of tumours and levels of the metal are increased in the serum and tumour tissue of patients affected by a range of cancers including prostate cancer (PCa). The molecular mechanisms that enable cancer cells to proliferate in the presence of elevated copper levels are, therefore, of key importance in our understanding of tumour growth progression. In the current study, we have examined the role played by the amyloid precursor protein (APP) in mitigating copper-induced growth inhibition of the PCa cell line, DU145. A range of APP molecular constructs were stably over-expressed in DU145 cells and their effects on cell proliferation in the presence of copper were monitored. Our results show that endogenous APP expression was induced by sub-toxic copper concentrations in DU145 cells and over-expression of the wild-type protein was able to mitigate copper-induced growth inhibition via a mechanism involving the cytosolic and E1 copper binding domains of the full-length protein. APP likely represents one of a range of copper binding proteins that PCa cells employ in order to ensure efficient proliferation despite elevated concentrations of the metal within the tumour microenvironment. Targeting the expression of such proteins may contribute to therapeutic strategies for the treatment of cancers.

Bibliographic note

Open Access funded by Cancer Research UK Under a Creative Commons license